Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,654 | 11,463 | 13,437 | 16,917 | 18,402 |
| Receivables | 297 | 322 | 256 | 182 | 165 |
| TOTAL | $15,507 | $13,033 | $14,898 | $17,391 | $19,083 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 4 | 4 | 5 |
| Other Non-Current Assets | 57 | 175 | 7 | 0 | 0 |
| TOTAL | $59 | $178 | $10 | $4 | $5 |
| Total Assets | $15,567 | $13,212 | $14,908 | $17,395 | $19,088 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,396 | 1,473 | 1,273 | 647 | 977 |
| TOTAL | $2,396 | $1,473 | $1,273 | $647 | $977 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22 | 18 | 475 | 0 | 0 |
| TOTAL | $N/A | $N/A | $475 | $N/A | $N/A |
| Total Liabilities | $2,396 | $1,473 | $1,748 | $647 | $977 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,287 | 15,033 | 13,899 | 13,927 | 13,910 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -44,041 | -40,465 | -37,985 | -34,185 | -32,650 |
| Other shareholders' equity | -76 | -50 | -13 | 6 | 47 |
| TOTAL | $13,171 | $11,739 | $13,160 | $16,749 | $18,111 |
| Total Liabilities And Equity | $15,567 | $13,211 | $14,908 | $17,395 | $19,088 |